Paper6785752
Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme.
Kamatani N and 2 others. Proc Natl Acad Sci U S A, 1981. Cited by 144 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme. Papers, record 6785752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6785752
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Pentosyltransferases | Major topic |
| Purine-Nucleoside Phosphorylase | Major topic |
| Adenosine | |
| Azaserine | |
| Breast Neoplasms | |
| Cell Line | |
| Cell Survival | |
| Humans | |
| Leukemia | |
| Melanoma | |
| Methotrexate | |
| Thionucleosides |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GM 23200 | NIGMS NIH HHS | United States | R01GM023200 | PubMed and NIH |
Source NIH RePORTER
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 444,479 | Metabolism of S-adenosylhomocysteine and S-tubercidinylhomocysteine in neuroblastoma cells. | Biochemistry | 1979 | https://conductscience.org/library/papers/444479 | PubMed |
| 2 | 197,412 | Human B cell, T cell and null cell leukaemic cell lines derived from acute lymphoblastic leukaemias. | Nature | 1977 | https://conductscience.org/library/papers/197412 | PubMed |
| 3 | 176,177 | Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis. | J Clin Invest | 1976 | https://conductscience.org/library/papers/176177 | PubMed |
| 4 | 4,567,231 | Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. | J Natl Cancer Inst | 1972 | https://conductscience.org/library/papers/4567231 | PubMed |
| 5 | 864,756 | Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. | J Natl Cancer Inst | 1977 | https://conductscience.org/library/papers/864756 | PubMed |
| 6 | 200,333 | Human leukemic "null" cell line (NALL-1). | Cancer | 1977 | https://conductscience.org/library/papers/200333 | PubMed |
| 7 | 14,164,575 | OBSERVATIONS ON POLYAMINES IN MALE ACCESSORY GLANDS OF REPRODUCTION. | Med Exp Int J Exp Med | 1964 | https://conductscience.org/library/papers/14164575 | PubMed |
| 8 | 870,189 | The prevention of methotrexate toxicity by thymidine infusions in humans. | Cancer Res | 1977 | https://conductscience.org/library/papers/870189 | PubMed |
| 10 | 178,611 | Establishment and characterization of a human histiocytic lymphoma cell line (U-937). | Int J Cancer | 1976 | https://conductscience.org/library/papers/178611 | PubMed |
| 11 | 324,781 | A method for combined 3H and 14C autoradiography with a single emulsion tested in cultured mammalian cells. | Exp Cell Res | 1977 | https://conductscience.org/library/papers/324781 | PubMed |
| 12 | 423,767 | Autoradiography. | Methods Enzymol | 1979 | https://conductscience.org/library/papers/423767 | PubMed |
| 13 | 179,629 | Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. | Biomedicine | 1975 | https://conductscience.org/library/papers/179629 | PubMed |
| 14 | 415,762 | Demonstration of 5'-methylthioadenosine phosphorylase activity in various rat tissues. Some properties of the enzyme from rat lung. | Biochim Biophys Acta | 1978 | https://conductscience.org/library/papers/415762 | PubMed |
| 15 | 637,906 | Thymidine rescue of high-dose methotrexate in humans. | Cancer Res | 1978 | https://conductscience.org/library/papers/637906 | PubMed |
| 16 | 4,174,339 | Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. | Cancer Res | 1968 | https://conductscience.org/library/papers/4174339 | PubMed |
| 17 | 6,932,523 | Tumorigenicity of human malignant lymphoblasts: comparative study with unmanipulated nude mice, antilymphocyte serum-treated nude mice, and X-irradiated nude mice. | J Natl Cancer Inst | 1980 | https://conductscience.org/library/papers/6932523 | PubMed |
| 18 | 14,278,051 | CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA. | Cancer | 1965 | https://conductscience.org/library/papers/14278051 | PubMed |
| 19 | 315,229 | Reaction of 5'-deoxyadenosine and related analogs with the 5'-methylthioadenosine cleaving enzyme of sarcoma 180 cells, a possible chemotherapeutic target enzyme. | Biochem Pharmacol | 1979 | https://conductscience.org/library/papers/315229 | PubMed |
| 20 | 4,357,758 | In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. | J Natl Cancer Inst | 1973 | https://conductscience.org/library/papers/4357758 | PubMed |
| 21 | 197,411 | Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line. | Nature | 1977 | https://conductscience.org/library/papers/197411 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 144 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,449,850 | Immunohistochemical Loss of MTAP as a Diagnostic and Prognostic Surrogate of CDKN2A/B Homozygous Deletion: A Narrative Review. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42449850 | PubMed |
| 39,725,169 | Interferon Epsilon Loss Is Elusive 9p21 Link to Immune-Cold Tumors, Resistant to Immune Checkpoint Therapy, and Endogenous CXCL9/10 Induction. | J Thorac Oncol | 2025 | https://conductscience.org/library/papers/39725169 | PubMed |
| 38,626,341 | De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression. | Cancer Res Commun | 2024 | https://conductscience.org/library/papers/38626341 | PubMed |
| 37,963,443 | The Pathology according to p53 Pathway. | Pathobiology | 2024 | https://conductscience.org/library/papers/37963443 | PubMed |
| 37,091,983 | Methylthioadenosine phosphorylase deficiency in tumors: A compelling therapeutic target. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37091983 | PubMed |
| 37,090,313 | Chronomodulated Administration of Chemotherapy in Advanced Colorectal Cancer: A Systematic Review and Meta-Analysis. | Cureus | 2023 | https://conductscience.org/library/papers/37090313 | PubMed |
| 36,913,304 | Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss. | Oncotarget | 2023 | https://conductscience.org/library/papers/36913304 | PubMed |
| 35,740,022 | Molecular Mechanisms behind Safranal's Toxicity to HepG2 Cells from Dual Omics. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35740022 | PubMed |
| 34,521,764 | Epigenetic Regulation of Fanconi Anemia Genes Implicates PRMT5 Blockage as a Strategy for Tumor Chemosensitization. | Mol Cancer Res | 2021 | https://conductscience.org/library/papers/34521764 | PubMed |
| 31,040,154 | MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation. | Cancer Res | 2019 | https://conductscience.org/library/papers/31040154 | PubMed |
| 30,214,457 | 4-Phenyl-1,3-thiazole-2-amines as scaffolds for new antileishmanial agents. | J Venom Anim Toxins Incl Trop Dis | 2018 | https://conductscience.org/library/papers/30214457 | PubMed |
| 29,668,680 | Mitochondrial nicotinamide adenine dinucleotide reduced (NADH) oxidation links the tricarboxylic acid (TCA) cycle with methionine metabolism and nuclear DNA methylation. | PLoS Biol | 2018 | https://conductscience.org/library/papers/29668680 | PubMed |
| 27,994,653 | Association of common variants in MTAP with susceptibility and overall survival of osteosarcoma: a two-stage population-based study in Han Chinese. | J Cancer | 2016 | https://conductscience.org/library/papers/27994653 | PubMed |
| 27,779,859 | Continuous Fluorescence Assays for Reactions Involving Adenine. | Anal Chem | 2016 | https://conductscience.org/library/papers/27779859 | PubMed |
| 26,751,376 | Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines. | PLoS One | 2016 | https://conductscience.org/library/papers/26751376 | PubMed |
| 26,559,752 | Six-layer structure for genomics and its applications. | J Hum Genet | 2016 | https://conductscience.org/library/papers/26559752 | PubMed |
| 22,464,254 | Primate genome gain and loss: a bone dysplasia, muscular dystrophy, and bone cancer syndrome resulting from mutated retroviral-derived MTAP transcripts. | Am J Hum Genet | 2012 | https://conductscience.org/library/papers/22464254 | PubMed |
| 21,301,207 | Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity: current strategies. | Cancer Biol Ther | 2011 | https://conductscience.org/library/papers/21301207 | PubMed |
| 21,131,597 | Chemical genetic screening for compounds that preferentially inhibit growth of methylthioadenosine phosphorylase (MTAP)-deficient Saccharomyces cerevisiae. | J Biomol Screen | 2011 | https://conductscience.org/library/papers/21131597 | PubMed |
| 19,478,948 | Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy. | PLoS One | 2009 | https://conductscience.org/library/papers/19478948 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MTAP | 4,507 | PubTator's text mining | https://conductscience.org/library/genes/4507 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6785752
GET https://conductscience.org/api/papers/v1/6785752/references?page=2